San Francisco,11 October 2018:
According
to a report published by Grand View Research, Inc.; the 3D
cell culture market is expected to reach a valuation of around USD 14.8
billion by 2024.
Factors such as introduction
of novel scaffolds and matrices and continuous developments in research and
analytical processes can drive the market over the forecast period (2014 to
2025). In addition, development of 3D optimized assays, kits, and protocols
coupled with advancements in assay techniques, is projected to accelerate
market growth.
Increasing need to implement
3D cell culture systems in research for better representation of in vivo
environment has lead the development of new materials and methods. This is
likely to fuel the market growth in the coming years. These systems are more
suitable for in vivo modeling as they provide similarity with morphology of
organ or cells. These systems can be available in several options such as 3D
bioreactor, scaffold-free, and scaffold-based systems. Introduction of scaffold-free
technology for development of translational pathway for tissues is likely to
support the market growth.
Worldwide cell culture market
can be segmented on the basis of technology, application, end-use, component,
and region.
Based on technology, the
market can be bifurcated into scaffold based, scaffold free, and 3D bioreactors.
The scaffold-free segment is expected to show rapid growth due to challenges associated
with scaffolds-based systems. These challenges include interference of
scaffolds with cell-to-cellular interactions and in assembly of cell produced extra
cellular matrices (ECM).
Access
Research Report of 3D
Cell Culture Market@ www.grandviewresearch.com/industry-analysis/3d-cell-culture-market
As per application, the market
can be split into cancer, tissue engineering and immunohistochemistry, drug
development, stem cell research, and others. The stem cell research segment is expected
to show lucrative growth on account of employment of cellular models for
differentiation and expansion of pluripotent stem cells-based on principle of
scaffolding.
On the basis of end-use, the
market can be categorized into biotechnology and pharmaceutical industries, research
laboratories and institutes, hospitals and diagnostic centers, and others.
In 2016, the biotech and
pharma segment estimated for the largest revenue share of over 47.0% due to
rapid adoption of these systems for toxicity screening, drug discovery, and
regenerative medicine development. These systems are preferred in drug
discovery due to their efficient screening and target validation capabilities.
Based on component, the market
can be classified into media and reagents and consumables.
The media segment occupies the
major portion as compared to other segments due to high requirements for media,
specifically in stem cell culture.
Geographically, the market can
be divided into North America, Europe, Asia Pacific, Latin America, and Middle
East & Africa. In 2016, North America estimated for the major market share of
over 41.0%.
Browse more reports of this category by
Grand View Research at: www.grandviewresearch.com/industry/healthcare
The U.S is the major
contributor in this region due to presence of established pharma and biotech
players work together with research laboratories to implement these
technologies. Majority of healthcare expenditure is utilized on chronic
diseases in the U.S, and Canada. This has resulted to rapid development of
three-dimensional cell culture products by the major players in this region.
Asia Pacific is expected to
witness the fastest growth over the forecast period due to developing
infrastructure in this region, coupled with increasing awareness about upcoming
technologies in healthcare amongst the population. Asia Pacific harbors 60.0%
of the world population; thus, even a lower prevalence of chronic diseases
translates into a large number of infected people, which is the leading factor
driving segment growth. Furthermore, unmet needs of patients and untapped areas
in this region have been attracting international market players and this is
expected to boost revenue generation through to 2024.
Asia Pacific is expected to
display significant growth during the forecast period due to robust developments
in the field of tissue engineering and stem cell research. The region is
anticipated to expand at a CAGR of 16% over the forecast period.
Prominent companies operating
in the market include Global Cell Solutions, Inc.; Nano3D Biosciences Corning
Inc.; 3D Biomatrix; Becton Dickinson and Company; and VWR International, LLC.
Major companies are
emphasizing on to form alliances with laboratories for commercialization of
technologies, which are not introduced to market.
Access
Press Release of 3D Cell Culture Market@ www.grandviewresearch.com/press-release/global-3d-cell-culture-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment